Microbial metabolites contribute to the pathogenesis of metabolic dysfunction-associated fatty liver disease in high-fat diet-fed mice
- 18 June 2026
- journal article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 218, 108634
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shenzhen Municipality (JCYJ20240813150239031)
- Natural Science Foundation of Shenzhen Municipality (JCYJ20240813150242034)
- National Natural Science Foundation of China (82170690)
- National Natural Science Foundation of China (82400834)
- National Natural Science Foundation of China (82400868)
- Basic and Applied Basic Research Foundation of Guangdong Province (2025A1515012746)
This publication has 56 references indexed in Scilit:
- Molecular insights into human phosphatidylserine synthase 1 reveal its inhibition promotes LDL uptakeCell, 2024
- Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver diseaseHepatology International, 2024
- Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver DiseaseJAMA, 2024
- Serum metabolomics-based heterogeneities and screening strategy for metabolic dysfunction-associated fatty liver disease (MAFLD)Clinica Chimica Acta, 2022
- Delicate regulation of IL-1β-mediated inflammation by cyclophilin ACell Reports, 2022
- Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese AdultsClinical Gastroenterology and Hepatology, 2022
- Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver DiseaseCell, 2019
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host MetabolismCell Metabolism, 2016
- Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesisHepatology, 2013
- Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes #Hepatology, 2009